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ABSTRACT: Chronically elevated sympathetic nervous activity underlies many cardiovascular diseases. Elucidating the
mechanisms contributing to sympathetic nervous system output may reveal new avenues of treatment. The contri-
butionof thegap junctionalproteinconnexin36 (Cx36) to the regulationof sympatheticactivityand thusbloodpressure
and heart rate was determined using amousewith specific genetic deletion of Cx36. Ablation of the Cx36 protein was
confirmed in sympathetic preganglionic neurons of Cx36-knockout (KO) mice. Telemetric analysis from conscious
Cx36KOmice revealedhigher variance inheart rate andbloodpressureduring rest andactivity compared towild-type
(WT) mice, and smaller responses to chemoreceptor activation when anesthetized. In the working heart–brain stem
preparation of the Cx36-KOmouse, respiratory-coupled sympathetic nerve dischargewas attenuated and responses to
chemoreceptor stimulation and noxious stimulation were blunted compared to WT mice. Using whole cell patch
recordings, sympatheticpreganglionicneurons in spinal cord slicesofCx36-KOmicedisplayed lower levels of spikelet
activity compared to WT mice, indicating reduced gap junction coupling between neurons. Cx36 deletion therefore
disrupts normal regulation of sympathetic outflow with effects on cardiovascular parameters.—Lall, V. K., Bruce, G.,
Voytenko, L., Drinkhill,M.,Wellershaus, K.,Willecke,K., Deuchars, J., Deuchars, S. A. Physiologic regulation of heart
rate andbloodpressure involves connexin 36–containing gap junctions. FASEB J. 31, 3966–3977 (2017).www.fasebj.org
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Normal physiology requires precise regulation of the car-
diovascular system,maintainingbloodpressureandcardiac
outputwithinappropriate ranges inresponse to internaland
external environmental changes. This maintenance is pro-
vided to a large extent by the autonomic nervous system (1).
Dysfunction of the autonomic nervous system, and in par-
ticular increased activity of the sympathetic branch, is as-
sociated with development, maintenance, and progression
of cardiovascular diseases such as hypertension (1) and
heart failure (2). Recent interventions for cardiovascular
diseases, which include renal nerve ablation, carotid sinus
denervation, carotid body ablation, carotid sinus stimula-
tion (3), and transcutaneous vagal nerve stimulation (4), all
lead to reduced sympathetic outflow. An increased un-
derstanding of sympathetic nervous control can therefore
offernewinsights into themechanismsunderlyingpotential
therapies and may reveal new targets for future therapies.
Recent advances using genetic modification for neuro-
nal tracing and optogenetics have considerably advanced
and consolidated knowledge of the central neuronal cir-
cuits underlying sympathetic control (5). Because sympa-
thetic preganglionic neurons (SPNs) are the last point in
the CNS where sympathetic outflow can be influenced,
regulation of their activity therefore provides a means of
controlling sympathetic activity.
The presence of gap junctions (GJs) between SPNs in-
fluences their activity because electronic coupling allows
transfer of electrical signals rapidly and securely between
coupled cells (5). Further, as 3 different gap junction
blockers reduced patterned rhythmic network activity in
the intermediolateral cell column (IML) of the spinal cord,
where SPNs are located (6), electrical coupling through
GJs may contribute to this activity. Because rhythmicity
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underlies sympathetic nerve activity (SNA) in normal car-
diovascular control (7), elucidating the contribution of GJs
in regulation of sympathetic activity and their influence on
thecontrolof thecardiovascular systemwouldenhanceour
overall understandingofwhat affects sympathetic outflow.
GJs in SPNs include the connexin 36 (Cx36) GJ protein
because Cx36 immunoreactivity has been detected be-
tween SPNs (8). Therefore, this study uses a multidisci-
plinary approach to investigate the roles of Cx36 in
autonomic control. We show that deletion of Cx36 causes
dysregulation of sympathetic outflow, cardiovascular
variables, and their reflex control. This dysregulation is
associatedwithdisruptionofnormalGJ coupling inSPNs.
MATERIALS AND METHODS
Experiments were performed under UK Home Office License
and in accordance with the regulations of the UK Animals
(Scientific Procedures) Act of 1986. Cx36flox cyan fluorescent
protein (CFP) mice (MGI ID 2178050; MGI symbol B6;129P2-
Gjd2tm4Kwi/Cnrm, EMMA ID EM:02510) were generated in
the laboratory of K.W. (9) as a genetic mixture (50%) of the
C57BL/6 and the 129 strain and then backcrossed to C57BL/6
so that they had 75% of C57BL/6 genetic background. For this
study, Cx36flox(CFP) homozygotes were crossed with phospho-
glycerate kinase I promoter (PGK)-Cre mice [MGI ID 2178050,
MGI symbol: Tg(Pgk1-cre)1Ln], which resulted in excision of
E1 and E2 in both alleles and knockout (KO) of Cx36 with
expression of CFP ubiquitously. These mice are henceforth re-
ferred to as Cx36-KO and wild-type (WT) littermates from
breeding with C57BL/6 were used as controls.
PCR
Ear samples were digested and genomic DNA extracted by fol-
lowing the DNeasy Blood and Tissue kit (Qiagen, Germantown,
MD,USA)orDirectPCR (ViagenBiotech, LosAngeles,CA,USA)
protocols. These involved an overnight proteinase K digestion
followed by heat inactivation of the enzyme and purification
(DNeasy only). For DNA obtained by the DNeasy protocol,
amplification and detection of the Cx36 gene was performed
in a 25-ml reaction mixture containing 12.5 ml HotStarTaq
Master Mix (Qiagen), 1.25 ml DMSO, 4.75 ml H2O, 5 ml DNA
template, and 0.5 ml each of the primers Cx36USP-1
(59-TAAGTGCAATAAAGGGGGAGGGCCTCG-39), Cx36DSP-1
(59-GAGACAGGAGAAGGTATTCCCAAGGGC-39,) and DSP-
CFP (59-AAGAAGTCGTGCTGCTTCATGTGG-39). PCR con-
ditions were 95°C for 5 min, 41 cycles at 95°C for 45 s, 56°C for
45 s, 72°C for 1 min, finishing with 72°C for 10 min. This re-
actionmixturewasmodified by increasing theH2O to 8.75ml to
accommodate a lower volume (1 ml) of DNA template when
using samples processed by the DirectPCR protocol. Ampli-
cons obtainedwere a 311-bpproduct for theWTCx36allele and
a 504-bp product for the Cx36-deleted allele. Heterozygotes
were distinguishable by the presence of both bands.
Immunohistochemistry
Because CFP levels in Cx36-KO reporter mice are insufficient to
be visualized directly, immunohistochemical methods were
used. Adult mice were deeply anesthetized with pentobarbital
solution (60mg/kg, i.p.) and transcardially perfusedwith 100ml
0.1M PBS (pH 7.4), followed by 200ml 4% paraformaldehyde in
0.1 M phosphate buffer (pH 7). The spinal cord was removed
from the animal and postfixed overnight. Coronal sections of
spinal cord tissue were taken at 30 to 50 mm on a vibrating mi-
crotome (Leica,Milton Keynes, United Kingdom) and incubated
with primary chicken anti–green fluorescent protein (GFP)
(Abcam, Cambridge, MA, USA) or rabbit anti-GFP (Thermo
Fisher Scientific, Waltham, MA, USA) and goat anti–choline
acetyltransferase (ChAT) (1:500; EMD Millipore, Billerica, MA,
USA). Alexa Fluor 555–conjugated donkey anti-chicken (1:1000;
Thermo Fisher Scientific) or Alexa Fluor 555–conjugated donkey
anti-rabbit (1:1000; Thermo Fisher Scientific) was used to localize
andvisualize the primaryantibodies. Secondaryantibodieswere
diluted in PBS and sections incubated for 3 h at room tempera-
ture. Sections were washed in PBS (33 for 10 min), mounted on
glass slides inVectashield (Vector Laboratories, Burlingame,CA,
USA), and viewed under an Eclipse E600 epifluorescence mi-
croscope (Nikon, Tokyo, Japan). Images were obtained using an
integrated CCD camera attached to an Acquis image-capture
system (Synoptics, Cambridge, United Kingdom). CorelDRAW
17 (Corel, Ottawa, ON, Canada) was used to adjust the image
brightness, contrast, and intensity, if required.
Telemetry
Implantation of telemetric probes
Experiments were performed on female homozygous Cx36-KO
mice and WT littermates (age 6–8 mo). Mice were anesthetized
with isoflurane (Merial, Harlow, United Kingdom) (5% in-
duction and 1.5–2% maintenance) and implanted with radiote-
lemetry probes (PA-C10; Data Sciences International, New
Brighton,MN, USA), which allowed continual measurements of
arterial blood pressure (ABP) (mmHg) and heart rate (beats per
minute, bpm). Blood pressure and heart rate were measured
from a catheter inserted into the carotid artery to the level of the
aorticarch.Thebodyof theprobewasplaced intoasubcutaneous
pocket, where it remained for the duration of the study. After
closure of the wound, the mice were placed into a recovery
chamber heated at 37°C until they recovered.
Mice were individually housed in their home cages in a
temperature-controlled room set to a 12:12-h light–dark cycle
with free access to food and water. After 7 d of recovery, the
telemetry probes were switched on. Running wheels were in-
troduced on d 3 after recovery.
Chemoreceptor stimulation
Micewere removed from cages, anesthetizedwith isoflurane (5%
induction and 1.5–2%maintenance), and placed on a heated pad
at37°C.Acatheterwas insertedviaasmall incision into the jugular
vein for intravenous drug administration. Peripheral chemore-
ceptorswere activated by administration ofNaCN (Thermofisher
Acros Organics, Geel, Belgium) intravenously at 0.3% diluted in
0.9% saline solution, administered in an intravenous bolus of 10
ml. These recordings were conducted during daylight hours.
Three trials were conducted per animalwith responses averaged;
at least 5 min of recovery was allowed between each trial.
Analysis
The average interbeat (R-R) interval (s), ABP (mmHg), and heart
rate (bpm) in allmicewere analyzed by using LabChart software
(ADInstruments, Oxford, United Kingdom) during 24-h diurnal
recordings or autonomic reflex stimulation. The average R-R
interval (s), ABP (mmHg), and heart rate (bpm) were analyzed
for 24 h with and without access to running wheels. The esti-
mated variance (the amount the heart rate or ABP changes per
unit of time) in ABP and heart rate was examined in Cx36-KO
mice compared to WT mice using Microsoft Excel (Microsoft,
Redmond, WA, USA).
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Peripheral chemoreceptor reflex responses were analyzed as
the peak increase or decrease in ABP and the greatest decrease in
heart rate after NaCN injection and are presented as percentage
change from baseline values. The magnitude of change in car-
diovascular parameters (heart rate and ABP) in response to
NaCN administration was compared to baseline levels and
expressed as percentage change from baseline values.
Working heart–brain stem preparation
Surgical procedures
Cx36-KO mice and WT littermates of either sex, between the
ages of 4 and 5 wk, were pretreated with heparin sodium salt
(6.2 mg/ml, i.p.; Alfa Aesar, Lancaster, United Kingdom)
before being deeply anesthetized with halothane. Working
heart–brain stem preparations (WHBPs) were surgically
prepared as previously described (10, 11); briefly, after sub-
merging the head and thorax in ice-cold artificial (a)CSF, de-
cerebration at the precollicular level was followed by skinning;
then the phrenic and sympathetic nerves were isolated and the
diaphragm, lungs, and surrounding organs removed. After re-
moval to a recording chamber, the descending aorta was can-
nulated and perfused retrogradely with aCSF.
Nerve recordings
Signals were recorded using glass suction electrodes attached
to a head stage (NL100; Digitimer, Welwyn Garden City,
United Kingdom) and fed into a Neurolog amplifier (1–2K
amplification; NL104; Digitimer). Signals were passed
through a Humbug (Quest Scientific, North Vancouver, BC,
Canada) to filter out mains noise at 50/60 Hz. Recordings
were sampled at 8 kHz and bandpass filtered between 50 Hz
and 4 kHz. All recordings were digitized using an interface
[CED 1401; Cambridge Electronic Design (CED), Milton,
Cambridge, United Kingdom] to be analyzed with Spike2
software (CED) off-line. The phrenic nervewas cut at the level
of the diaphragm and bursts of phrenic nerve discharge
(PND) recorded from the central end. Central SNA was
recorded from the lower thoracic sympathetic chain using a
second glass suction electrode.
Autonomic reflexes
Peripheral chemoreceptors were stimulated with NaCN (0.03%;
0.1 ml diluted in 0.9% NaCl solution) injected directly into the
descending aorta via the side arm of the perfusion cannula. The
baroreceptor reflex was stimulated by transiently increasing
perfusion flow rate. Noxious stimulation was applied to the
forelimbs using manually operated hemostats for 2 s.
Solutions
aCSF solution contained (inmM): 125 NaCl, 24 NaHCO3, 5 KCl,
2.5 CaCl2, 1.25 MgSO4, 1.25 KH2PO4, and 10 D-glucose. In ad-
dition, 1.25%Ficoll (type70; Sigma-Aldrich,St. Louis,MO,USA)
was added to the perfusate; pHwasmeasured at 7.356 0.05.
Analysis
Stable periods of baseline PNDwere amplified and filtered, then
integratedandrectified (timeconstantof100ms).PNDfrequency
(bursts per minute) was calculated over at least 50 respiratory
cyclesduringbaseline recordings.ThePNDwas calculated as the
sum of the total inspiration duration and total expiration dura-
tion. Heart rate (bpm) was deduced from the electrocardiogram.
During autonomic interventions, 3 trials per preparation were
averaged. During each intervention, the PND rate and heart rate
were analyzed immediately after the stimulus for 5 to 7 re-
spiratory cycles. These data were then expressed as a percentage
change from baseline values. Alterations in sympathetic activity
were analyzedby calculating the average rectifiedand integrated
sympathetic nervedischarge (
R
SND) (with a time constant of 100
ms) during autonomic reflex stimulation and compared against
the average of 2 equivalent control periods of
R
SND before and
after the stimulus. This was performed using a custom-written
Spike2 script, described previously (12). Because we were mea-
suring changes in sympathetic activity, not baseline or absolute
levels, noise levels were not subtracted during the analysis. The
electrocardiogram was graphically removed from some traces,
where appropriate, to allow clarity.
To analyze respiratory-related sympathetic bursts, the am-
plitude of rectified and integrated
R
SND for the first 200 ms of
the PND (start of the augmenting phase, considered early in-
spiration) wasmeasured and compared to the
R
SND amplitude
for the first 200 ms of silencing of the phrenic nerve. These 2
amplitudes were expressed as a ratio to give a measure of the
degree of respiratory-related
R
SND in the 2 conditions.
The degree of bradycardia was measured as the percentage
change in heart rate (bpm) from baseline heart rate to the lowest
level of heart rate after chemoreceptor stimulation. Unless oth-
erwise stated, data are presented as group means 6 SEM, and
differences were considered significant at the 95, 99, and 99.5%
confidence limit. Statistical significance is representedasP,0.05,
P , 0.01, and P , 0.005, respectively. Data were tested for sig-
nificance as stated within the results; n represents the number of
preparations.
Electrophysiology
Neonatal (7–14 d) mice of either sex, Cx36 KO, WT, or hetero-
zygous, were deeply anesthetized with sodium pentobarbital
(60mg/kg, i.p.).Anear samplewas taken for post hocgenotyping
beforehand, and the experimenters were blinded to the geno-
types of the mice during the recordings and for analysis.
Transcardial perfusionwith ice-cold sucrose aCSF containing
(mM) 217 sucrose, 26 NaHCO3, 3 KCl, 2 MgSO4×7H2O, 2.5
NaH2PO4, 10 glucose, and 1 CaCl2, buffered with 95% O2–5%
CO2, was carried out. The animal was decapitated and the tho-
racic spinal cord removed and cut (300 mm) on a vibrating mi-
crotome (13), then placed in an immersed holding chamber
containing aCSF composed of (mM) 124 NaCl, 26 NaHCO3, 3
KCl, 2 MgSO4×7H2O, 2.5 NaH2PO4, 10 glucose, and 2 CaCl2,
equilibrated with 95% O2–5% CO2.
IML neurons were visually targeted and identified as pre-
viously described (13). Patch electrodes with resistances of 4 to
7MVwere filledwith intracellular solution containing (mM) 110
K-gluconate, 11 EGTA, 2 MgCl2·6H2O, 0.1 CaCl2, 10 HEPES, 2
Na2ATP, and 0.3NaGTP, pH7.2, 285 to 290mOsm. The voltage-
gated sodiumchannel blockerQX-314 bromide (2–4mM;Ascent
Scientific, Bristol, United Kingdom)was included to block action
potentials in the recorded neuron, thus unmasking the un-
derlying coupled activity. The tracers neurobiotin (0.5%) and
dextran–rhodamine (0.02%) were also included to allow post hoc
morphologic analysis. These diffused into the neuron during
recording with QX-314–bromide, abolishing evoked action po-
tentials within 5 min of going whole cell.
Hyperpolarizing and depolarizing current pulses (610–100
pA, 1 s duration, 0.14 Hz) were used to characterize recorded
neurons as either SPN or interneurons on the basis of their re-
sponses (13). Neurons were held at 250 mV for the duration of
the experiment. Drug solutions were bath applied (3–5 ml/min)
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for a minimum of 5 min. The drug used was 5-hydroxytrypta-
mine (5-HT, 10 mM; Sigma-Aldrich) dissolved in aCSF.
Recovery of filled neurons
The electrode was carefully withdrawn from the slice. Slices
were transferred on a slide to an epifluorescent microscope to
image dextran–rhodamine fluorescence before fixation or
were fixed with 4% paraformaldehyde + 0.25% glutaralde-
hyde overnight at 4°C when only neurobiotin was present.
After resectioning at 50mm, neurobiotinwas visualized using
extravidin peroxidase (1:250) and 3,39-diaminobenzidine
staining.
Analysis
Datawere acquired at 10 kHz, filtered at 3 kHz, and logged into a
computer using Spike2 v.4.1 software (CED) through a 1401plus
A/D converter (CED). Off-line analysis was performed using
Spike2 v7, and “spikeletlike” events were evaluated and quan-
tified using Mini Analysis (Synaptosoft, Decatur, GA, USA).
Statistical analysis was performed by Prism 5 software
(GraphPad Software, La Jolla, CA, USA); results are provided
as means6 SEM where appropriate.
RESULTS
Spinal expression of CFP in Cx36-KO
reporter mice
Cells harboring the Cx36 deletion express the reporter
protein CFP, enabling localization of Cx36-expressing
cells. In Cx36-KO mice, numerous Cx36-expressing
neurons were found in each spinal cord segment ana-
lyzed, from the first cervical to the third lumbar seg-
ment (n = 9 mice; Figs. 1A and 2). Analysis of the
distribution of cells in 50-mm spinal hemisections (Fig.
1B; n = 3 mice, n = 6–11 sections) revealed that the
largest percentage of CFP-expressing cells was located
in the superficial dorsal horn (C2, 85.5%; C5, 86.2%; T2/3,
70.7%; L3/4, 72.3%) and that the average number of
cells in the dorsal horn varied with spinal cord seg-
ment (Fig. 1B). Fewer cells were labeled in the ventral
horn, intermediomedial, and/or central cervical nu-
cleus and in the IML (Fig. 1B). To determine whether
CFP-expressing neurons within the IML region were
SPNs, sections were dual labeled for CFP and ChAT (a
marker of cholinergic cells; Fig. 2). CFPwas detected in
94% of ChAT-immunopositive neurones in the IML,
indicating that they are SPNs and that Cx36 is ablated
in these neurons (Fig. 2B1–B3).
Free-moving Cx36-KO mice have lower resting
heart rate and ABP than WT mice
Average heart rate, measured using telemetry over a 24 h
period, was lower in Cx36-KO mice (582.2 6 1.3 bpm,
mean6 SEM) thanWTmice (629.36 1.5 bpm) (P, 0.001,
2-sample Student’s t test; n = 4; Fig. 3A–C). Furthermore,
heart rate variance (a statistical measure of how far values
in a data set deviate from themean) in Cx36-KOmicewas
significantly higher (2256.62 6 1.5) than in WT mice
(1749.126 1.3; n = 4; P, 0.001, F test; Fig. 3A–C).
ABP was lower in Cx36-KO mice (100.66 0.3 mmHg)
compared to WT mice (113.6 6 0.3 mmHg) (n = 4; P ,
0.001, 2-sample Student’s t test; Fig. 3A–C); however, ABP
variance was not significantly different (Cx36-KO mice,
79.5260.7;WTmice, 84.8260.5;n=4,P=0.224,F test; Fig.
3A–C).
Free-moving Cx36-KO mice with access to
running wheels display augmented variance
in ABP and heart rate compared to WT mice
InCx36-KOmicewith access to runningwheels, heart rate
was lower (552.26 2.63 bpm; WT 629.36 1.1; n = 4; P,
0.001, 2-sample Student’s t test; Fig. 3A–C) while variance
Figure 1. Distribution of CFP-expressing neurones in spinal cord. A) Representative hemisections of spinal cord at different
segmental levels; each circle represents a single CFP-positive neuron in a single 50-mm section. B) Average number of CFP-labeled
neurons in single 50-mm sections 6 SE from different spinal cord segments. LI–LIII, laminae I–III; IMM, intermediomedial nucleus;
LVIII–IX, laminae VIII–IX.
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was significantly higher (7042.32 6 2.7) than that of WT
mice (1228.92 6 1.1; n = 4; P , 0.001, F test; Fig. 3A–C).
Furthermore, ABP (109.6 6 0.3 mmHg) was lower than
WTmice (114.06 0.3mmHg; P = 0.01, 2-sample Student’s
t test; n = 4; Fig. 3A–C). Variance in ABP in Cx36-KOmice
(118.92 6 0.3) was higher compared to WT mice (68.42 6
0.3; n = 4, P , 0.01, F test; Fig. 3A–C). Values are sum-
marized inTable 1. This suggests that during exercise, the
regulation of ABP is impaired in Cx36-KO mice.
Anesthetized Cx36-KO mice exhibit
attenuated heart rate responses to peripheral
chemoreceptor stimulation compared to
WT mice
Chemoreceptor stimulation increased ABP and elicited a
pronounced bradycardia in anesthetized Cx36-KO and
WTmice. InWTmice,ABP increasedby16.361.2mmHg;
in Cx36-KO animals, this increase was attenuated com-
pared to WT mice (9.4 6 1.3 mmHg; P = 0.01, 2-sample
Student’s t test). The R-R interval in WT mice (0.114 6
0.001 s at baseline) was increased by 0.0236 0.007 s at the
peak of the chemoreceptor stimulation response. In
Cx36-KO mice, this increase in R-R interval was
significantly smaller (n = 4; P = 0.03, 2-sample Student’s
t test; Fig. 3D) such that chemoreceptor stimulation only
caused an 0.0066 0.0002 s increase in R-R interval from
a baseline value of 0.110 6 0.006 s. Thus, bradycardia
upon peripheral chemoreceptor stimulation was at-
tenuated in Cx36-KOmice (35.96 10.8 bpm) compared
to WT (84.9 6 21.8 bpm; P = 0.01, 2-sample Student’s
t test; Fig. 3D).
Resting heart rate and sympathetic activity
are lower in the WHBP of Cx36-KO mice
compared to WT mice
To investigate whether Cx36-containing GJs contribute to
the regulation of SNA, direct recordings of SNA were
obtained in the anesthesia-free WHBP.
Similar to data from conscious animals, in theWHBP
heart rate was significantly lower in Cx36-KO mice
(415.76 25.2 bpm) thanWTmice (525.26 15.9 bpm; n =
21;P= 0.001, 2-sample Student’s t test; Fig. 4A) despite a
higher respiratory rate in the WHBPs of Cx36-KO (Fig.
4A, B). Sympathetic nerve discharge (SND) typically
exhibited tonic activity with characteristic respiratory-
related increases in discharge in both WT mice and in
Cx36-KO mice. However, the degree of respiratory-
related SND was 19.2% smaller in Cx36-KO mice com-
pared to WT mice. The ratio between the SND during
the first 200 ms of expiration and the first 200 ms of
inspiration was 1.06 0.1 inWTmice, while in Cx36-KO
mice the ratio decreased to 0.8 6 0.0 (n = 6; P = 0.02,
2-sample Student’s t test; Fig. 4B).
Using the WHBP of Cx36-KO mice, sympathetic
responses to peripheral chemo- and
nociceptive stimuli are smaller than those of
WT mice but baroreceptor responses
are similar
In Cx36-KO mice, the sympathoexcitation of 71.7 6 60.1
arbitrary units (AU) (n = 12) in response to peripheral
chemoreceptor stimulation (0.03%NaCN injected into the
descendingaortavia the side armof theperfusion cannula)
was significantly smaller than that observed in WT mice
(163.3 6 36.1 AU; n = 15; P = 0.001, 2-sample Student’s
t test; Fig. 4C), although differing baseline levels of SND in
WT and KOmay have influenced the amplitudes of these
responses. The average bradycardia upon chemoreceptor
activationwas lower in Cx36-KOmice (141.76 17.4 bpm)
than in WT mice (211.8 6 25.1 bpm; n = 15; P = 0.033).
Nociceptive stimulation (elicited to the forelimbs using
manually operated hemostats for 2 s) also caused sym-
pathoexcitation in bothCx36-KOandWTmice.However,
in Cx36-KO mice, this sympathoexcitation was signifi-
cantly smaller (54.9 6 16.7 AU, n = 12) compared to WT
mice (100.2 6 18.5 AU; n = 15; P = 0.029, 2-sample Stu-
dent’s t test; Fig. 4D).
Baroreceptor stimulation (transient increase in perfu-
sion flow rate) resulted in a sympathoinhibition of 72.46
15.0 AU in Cx36-KO mice, which was not significantly
different from that of WT mice (67.6 6 11.9 AU) (n = 15;
Figure 2. SPNs express CFP. A) Photomontage of thoracic
spinal cord hemisection illustrating examples of CFP-labeled
neurons. Grayscale images were inverted and brightness/
contrast adjusted to facilitate visualization of labeled neurons.
CC, central canal; DH, dorsal horn; VH, ventral horn. B1–B3)
Example of neurons in IML expressing CFP (B1) and ChAT
(B2) and combined to illustrate dual labeling (B3). Single-scan
confocal slice; arrow indicates exemplar cell in all images.
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P = 0.784, 2-sample Students t test; Fig. 4E). Therewas also
no change in the baroreceptor reflex gain sensitivity
(expressed as the change in heart rate (bpm) per 1 mmHg
change in perfusion pressure) betweenCx36-KOmice and
WT mice (25.9 6 0.5 and 25.5 6 0.6 bpm mmHg 21,
respectively) (n = 15; P = 0.588, 2-sample Student’s t test),
although it must be noted that the starting heart rate was
significantly lower in the Cx36-KO animals, which may
influence the results. There were no significant differences
in the mean level of inspiratory related or expiratory
related
R
SND between WT (n = 15; P = 0.364) and Cx36-
KO mice (P = 0.140, 2-sample Student’s t test; n = 15).
SPN recordings in spinal cord slices show
lower levels of spikelet activity in Cx36-KO
mice compared to WT mice
To determine whether GJ coupled activity between SPNs
is reduced in Cx36-KOmice, single recordings from SPNs
Figure 3. Cx36-KO mice have augmented variance in ABP and heart rate but reduced responses to chemoreceptor stimulation.
A) Average ABP and heart rate from all animals for WT and Cx36-KO mice taken every 1 min over 5-d period. Solid arrows
denote addition of free running wheel; black-and-white bar at bottom, light–dark cycle. B) Average data over 24-h period without
running wheel (d 2) and with running wheel (d 4) as indicated by white boxes in A. C) Summary data of ABP and heart rate in
Cx36-KO and WT mice, with (right) and without (left) running wheels. Variance is indicated by range of change in ABP and
heart rate; black asterisks indicate signiﬁcant changes in variance. Average (median) heart rate and ABP are indicated by solid
line in box plots; gray asterisks denote signiﬁcance. D) Change in ABP, R-R interval, and heart rate upon chemoreceptor
stimulation in WT and Cx36-KO mice. *P , 0.05, **P , 0.01, ***P , 0.005.
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were made in spinal cord slices from WT and Cx36 het-
erozygous and KOmice.
SPNs fromWT(n=79), heterozygous (Cx36+/delCFP,n=
83), and Cx36-KO (n = 60)micewere recorded. These cells
were characterized as SPNon thebasis of a combination of
their anatomic location and responses to positive and
negative current pulses, and these did not differ between
mouse genotypes, as expected from previous studies (14).
Because the majority of SPNs (94%) in the IML are CFP
positive, they were not verified for CFP in Cx36-KO slices
during these experiments. Those cells imaged using
dextran–rhodamine or diaminobenzidine in bothWT and
Cx36-KO mice displayed the characteristic mediolateral
orientation of SPNs with somata located within the IML,
medially projecting dendrites, and ventrally projecting
axon (Fig. 5B). This similar morphology fits with recent
observations that in older mice, there is no significant
difference in number or length of primary dendrites be-
tween Cx36-KO and WT mice (15). Consistent with pre-
vious observations in rat SPNs (16), spontaneous coupled
activity in the form of spikelets was observed in 27.8% of
WTSPNsheldat250mV(n=22/79; Fig. 5A),withamean
frequencyof 0.36 0.08Hz (n=16).Neither prevalence nor
frequency of spontaneous spikelet activity were signifi-
cantly different in heterozygotes (n= 16/83, 0.36 0.11Hz)
compared to WT mice. Importantly, most SPNs (97%) in
the Cx36-KO mice did not exhibit spikelets; prevalence
was thus significantly lower compared to both WT and
heterozygotes (P , 0.0001, Fisher’s exact test; Fig. 5A).
Furthermore, in those 2 SPNs where some spikelets were
observed, their frequency was significantly lower (0.1 6
0.09 Hz) in Cx36-KO compared to WTmice.
Application of 5-HT has excitatory effects on SPNs,
which includes increasing the prevalence of spikelets (16).
AsmostSPNsarequiescent, 5-HT(10mM)applicationwas
used to induce spikelets in these cells. Depolarization in
response to 5-HT was equally prevalent between WT
(51.2%), heterozygote (48.9%), and Cx36-KO (47.2%)
SPNs, with no observable difference in amplitude of de-
polarization (6.8 6 1.0 mV WT; 5.6 6 1.0 mV, heterozy-
gotes; 5.96 1.2mV,Cx36KO;P. 0.7;Fig. 6A,B). This is in
contrast to the induction or augmentation of spikelet ac-
tivity in the presence of 5-HT, which remained equally
inducible in WT (48.8%) and heterozygotes (51.1%), but
the percentage of SPNs in Cx36-KO animals that respon-
ded to 5-HTwith spikeletswas significantly lower (16.7%;
Fig. 6A, B) than the other groups. The effect of 5-HT on
spikelet frequency in responsive SPNs remained signifi-
cant (P, 0.001, 2-way ANOVA) across all genotypes, but
there was a significant reduction in mean frequency be-
tween WT (1.16 6 0.2 Hz, n = 20) and Cx36-KO (0.298 6
0.13 Hz) mice (P, 0.05, 2-way ANOVA, Fig. 6C).
DISCUSSION
This study is the first to show that KO of the Cx36 GJ
protein results in abnormal physiologic regulation of ABP
and heart rate in freely moving mice. Utilizing theWHBP
preparation revealed that Cx36 KO disrupted SNA, heart
rate, and ABP. A reduction in spikelet activity (which is
considered to be due to GJ coupling between SPNs (17))
was observed between SPN of Cx36-KO mice. Together,
these results reveal reduced sympathetic activation and a
loss of temporal coordination of this activity upon loss of
Cx36.
Cx36-containing GJs preferentially influence
sympathetic autonomic activity
KO of Cx36 preferentially affects sympathetic over para-
sympathetic nervous activity. The vagal outflow to the
heart was unaffected by Cx36 KO because baroreceptor
reflex sensitivity did not change. However, converging
observations in the Cx36-KOmice indicate Cx36 influence
on the sympathetic nervous system are: 1) significantly
increased variability inABP is consistentwith an impaired
sympathetic baroreflex; 2) a blunted reflex bradycardia
after chemoreceptor stimulation is due to initial vagal ac-
tivation but with a contribution from sympathetic with-
drawal (18); and 3) attenuation of sympathoexcitation
upon peripheral injections of NaCN or to noxious stimu-
lation. It must be noted that baseline parameters are
changed in theCx36-KOanimals,whichmay influence the
amplitudes of the responses observed to baroreceptor,
chemoreceptor, or noxious stimulation. However, similar
blunted chemoreflex responses are observed in patients
with multiple system atrophy where there is a profound
loss of both pre- and postganglionic neurons (19, 20).
The absence of Cx36 therefore has major consequences
on central sympathetic drive; this is consistent with the
resting bradycardia observed in Cx36-KO mice, which is
unlikely to be due to direct effects on the heart as neuronal
Cx36 is not expressed here (21). Because chemical thoracic
TABLE 1. Average pressure and average heart rate in WT and Cx36-KO mice with and without access
to running wheels
Wheel
WT Cx36 KO
Blood pressure
(mmHg) Heart rate (bpm) Blood pressure (mmHg) Heart rate (bpm)
Without 113.6 6 0.3 629.3 6 1.5 100.6 6 0.3*** 582.2 6 2.8***
84.82 6 0.5a 1749.12 6 1.3a 79.52 6 0.7a 2256.62 6 1.5***a
With 114.0 6 0.3 629.3 6 1.1 109.6 6 0.3* 552.2 6 2.6***
68.42 6 0.3a 1228.92 6 1.1a 118.92 6 0.3**a 7042.32 6 2.7***a
aVariance. *P , 0.05, **P , 0.01, ***P , 0.005.
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Figure 4. In WHBP Cx36-KO mice have reduced respiratory-related SNA and attenuated responses to chemoreceptor and
noxious stimulation. A) Raw data from Cx36-KO mice showing heart rate, PND, and SND. On right, group data illustrate reduced
resting heart rate in Cx36-KO mice. B) Raw data of SND and PND, with inspiratory and expiratory phases of respiratory cycle
marked as total inspiration (Ti) and total expiration (Te), respectively. Group data on right shows attenuated respiratory-related
SND in Cx36-KO mice. C) Peripheral chemoreceptor stimulation (arrows) in WT and Cx36-KO mice. Group data show that
percentage sympathoexcitation upon chemoreceptor stimulation is signiﬁcantly reduced in Cx36-KO mice. D) Noxious
stimulation (arrow) elicited short latency increase in SND in both groups, but this was signiﬁcantly diminished in Cx36-KO mice
and is shown by group data on right. E) Sympathoinhibition resulting from baroreceptor stimulation was not signiﬁcantly
different in Cx36-KO mice compared to WT mice. *P , 0.05, **P , 0.01, ***P , 0.005.
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sympathectomy results in a pronounced bradycardia, this
suggests that reduced sympathetic activity can indeed
have depressant effects on heart rate (22). Furthermore,
this bradycardia is consistent with data from patients
taking mefloquine (which affects Cx36 GJs) for malaria
prophylaxis (23); the fact that this drug crosses the
blood–brain barrier (24) may mean that the bradycardic
effects observed are due at least in part to loss of Cx36-
containing GJs, resulting in disrupted central sympathetic
activity. The bradycardia may be due to sympathetic
withdrawal via changes in GJ coupling in the central con-
nections between the nucleus of the solitary tract, the
ventrolateral medulla, and SPNs, but a major likely site is
at the level of the SPNs themselves. It could be also argued
that thebradycardia andreducedbloodpressureobserved
in Cx36-KOmicemay be due to reduced physical activity
of thesemice associatedwith loss of Cx36 inmotor circuits
rather than specific loss of Cx36 at the level of SPNs in-
nervating these cardiovascular targets. There are, how-
ever, no studies indicating reduced locomotor activity in
Cx36-KOmice (25).
Loss of Cx36-containing GJs in the SPNs may
underlie some of the effects observed
The Cx36-KO model used here is a global KO, and the
effects observedmay thus be due to loss ofGJ function at a
number of sites. For example, Cx36 is expressed in the
pancreas, although Cx36-KO mice have normal plasma
insulin and glucagon levels and no difference in fasting
glucose levels (26), so it is unlikely that this would have a
significant effect on sympathetic activity. One likely locus
for at least someof theeffects ofKOofCx36-containingGJs
on SNA is SPNs. SPNs in the KOmice express CFP,which
indicates Cx36 expression. In addition, in spinal cord sli-
ces, the incidence of spikelets is much reduced in SPNs
recorded from Cx36-KO mice, although not completely
abolished, similar to that observed in thalamic reticular
nucleus neurons (15). This suggests that a potential site of
action for the altered cardiovascular responses in the Cx36
KO is via the GJs between SPNs. This is further supported
byprevious data usingpaired recordings that demonstrate
synchronization of action potential firing and spikelets
between electrotonically connected SPNs (17). Further-
more, rhythmic network activity recorded from the IML is
reduced with the broad spectrum GJ blocker carbenox-
olone and can be abolished by the Cx36 GJ blocker meflo-
quine (6).Wedonot rule out thepossibility that someof the
changes in cardiovascular and sympathetic variables ob-
served in our study aredue to loss ofCx36 in other neurons
(potentially including those in the sympathetic ganglia)
that form part of the sympathetic circuits underlying car-
diovascular control (27). However, it is likely, both from
our results and fromprevious research (8), that at least one
factor underlying the changes is SPN-specific loss of Cx36-
containing GJs. To address this directly would require
targetedKOof SPNs in future studies once such transgenic
models for targeting SPNs are available.
The sympathetic nervous system requires coordination
of functionally related activity across a large column of
Figure 5. Spikelet frequency in SPNs is reduced in Cx36-KO mice. A) Representative traces taken from single SPNs (held at
260 mV) recorded in spinal cord slices of Cx36-KO, heterozygous (Cx36+/delCFP), and WT mice showing lack of ongoing
spikelet activity in Cx36-KO compared to other 2 groups. Histogram to right is grouped data showing prevalence of spikelets
in SPNs from 3 groups. In those 2 SPNs in Cx36-KO mice where spikelets were observed, neither frequency nor amplitude of
spikelets was signiﬁcantly different from heterozygous or WT animals. B) Typical morphology of SPN in WT. Note axon heading
ventrally and mediolaterally orientated dendrites (arrows).
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Figure 6. 5-HT-induced spikelet activity is signiﬁcantly attenuated in Cx36-KO mice. A) Representative traces taken from single
SPNs in spinal cord slices of Cx36-KO, heterozygous (Cx36+/delCFP), and WT mice showing responses to bath application of
10 mM 5-HT (black line denotes time of application; negative current was added to bring resting membrane potential to initial
starting value of 260 mV). Dashed lines show areas of trace that are shown at right on faster time base to clearly see spikelets.
B) Pooled data of percentage of SPNs in 3 groups that were depolarized by 5-HT (top) and percentage that showed 5-HT induced
coupled activity (bottom). C) Pooled data from 3 groups showing effect of 5-HT on frequency of spikelets only in SPNs that
responded with change in spikelet occurrence or frequency.
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neurons, and GJ expression may be consistent with this
functional specialization of sympathetic outflow. GJ ex-
pression between SPNs with the same autonomic
functions may play an important role in coordinating
the activities of different neurons involved in the same
sympathetic response. In this way, GJs may coordinate
populations of neurons to produce a synchronized re-
sponse rather than increasing basal levels of SND. In
spinal cord slice preparations, only about a quarter of
SPNs exhibit GJ coupling in the form of spikelets (17),
which would indicate some degree of functional spec-
ificity; recent evidence using the WHBP has supported
such a suggestion (28).
We found that there were still some incidences of
spikelet activity in Cx36-KO animals, in keeping with
previous reports using these KO animals where some
coupled activitywas preserved (15) orwhen dye coupling
was observed in a small percentage (14%) of thalamic re-
ticular nucleus neurons (29). Despite use of neurobiotin in
the recording electrode, we did not observe dye coupling
in SPNs in either the WT or KO mice, regardless of the
presence of spikelets. Similar lack of dye coupling in these
spinal cord neurons has been reported previously (17).
Functional GJ expression in adult rodents
There is still debate over the contribution of GJs to SPN
coordinated activity in adults because some consider that
GJ expression in these neurons is a developmental phe-
nomenon (5) and thus may not contribute to sympathetic
outflow in adults. However, the Cx36 protein is immu-
nohistochemically detected in SPNs in adult rat (8), and
pharmacologic blockade of Cx36-containing GJs influ-
enced sympathetic variables in rats aged 4 to 6 wk (10).
Furthermore, GJ coupling between SPNs in adult spinal
cord slices was reported in a brief communication (30),
while in theWHBP of increasing age from P5 to P16, there
is no reduction in thenumberofSPNs that exhibit spikelets
(28). This current study supports this evidence because
Cx36 KO alters cardiovascular regulation in adult mice.
This may also apply to humans, as patients taking the
Cx36 blocker mefloquine as an antimalarial agent exhibi-
ted a significant bradycardia 6 d after administration (23).
Cx36-mediated GJ therefore appears important for central
control of the cardiovascular system in adult mammals.
Functional significance of findings
Chronically elevated levels of SNA are associated with
disorders includingheart failure, obesity, obstructive sleep
apnea, and hypertension (31). Evidence to support a role
for the sympathetic nervous system in controlling ABP is
well documented; chemical sympathectomy in un-
anesthetized rats significantly increased ABP variability
(32, 33). Our data indicate that Cx36 is likely involved in
the precise regulation of SNA (and thus heart rate and
ABP) during periods of rest, activity, or specific pertur-
bation, such as noxious stimulation. Indeed, in Cx36-KO
mice, the variance in heart rate and BP resulting from the
introduction of a running wheel was at least twice that of
WT. Loss of Cx36may result in decreased vasomotor tone
and a loss of precise control of cardiac output or vaso-
constriction by the SPNs acting on the heart and blood
vessels. Means to modulate GJs may therefore be a wel-
come noninvasive therapy for restoring the sym-
pathovagal balance that underlies many disorders.
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